Correlation Between CHUBB and Catalyst Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CHUBB and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHUBB and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CHUBB P 6 and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on CHUBB and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHUBB with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHUBB and Catalyst Pharmaceuticals.

Diversification Opportunities for CHUBB and Catalyst Pharmaceuticals

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CHUBB and Catalyst is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding CHUBB P 6 and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and CHUBB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHUBB P 6 are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of CHUBB i.e., CHUBB and Catalyst Pharmaceuticals go up and down completely randomly.

Pair Corralation between CHUBB and Catalyst Pharmaceuticals

Assuming the 90 days trading horizon CHUBB P 6 is expected to generate 0.42 times more return on investment than Catalyst Pharmaceuticals. However, CHUBB P 6 is 2.35 times less risky than Catalyst Pharmaceuticals. It trades about 0.3 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest  10,675  in CHUBB P 6 on September 13, 2024 and sell it today you would earn a total of  613.00  from holding CHUBB P 6 or generate 5.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy86.36%
ValuesDaily Returns

CHUBB P 6  vs.  Catalyst Pharmaceuticals

 Performance 
       Timeline  
CHUBB P 6 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CHUBB P 6 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CHUBB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

CHUBB and Catalyst Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CHUBB and Catalyst Pharmaceuticals

The main advantage of trading using opposite CHUBB and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHUBB position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.
The idea behind CHUBB P 6 and Catalyst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets